Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2393100

Cl.Cl.O=C(O)c1c(Cl)c(Cl)c(C(=O)O)c(Cl)c1Cl

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 known ✓ P27487 1/20 0.42
CA2 known ✓ P00918 1/20 0.35
TTR known ✓ P02766 1/20 0.32
HTT P42858 1/20 0.40
CYP1A2 P05177 2/20 0.38
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
ALDH1A1 P00352 3/20 0.36
HSD17B10 Q99714 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TSHR P16473 3/20 0.35
ALOX15 P16050 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
TPMT P51580 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11671966 1.00 DPP4 (0.42) DPP4HTTCYP1A2CES2CES1
SCHEMBL4899263 0.96 DPP4 (0.43) DPP4HTTCYP1A2CES2CES1
SCHEMBL70425 0.96 DPP4 (0.43) DPP4HTTCYP1A2CES2CES1
SCHEMBL205832 0.93 HTT (0.45) DPP4HTTCYP1A2CES2CES1
Hydrochloric Acid SCHEMBL29253982 0.93 DPP4 (0.42) DPP4HTTCYP1A2CES2CES1
Hydrochloric Acid SCHEMBL10715453 0.90 HTT (0.48) DPP4HTTCYP1A2CES2CES1
SCHEMBL10617916 0.90 HTT (0.43) DPP4HTTCYP1A2CES2CES1
SCHEMBL6903601 0.90 HTT (0.48) DPP4HTTCYP1A2CES2CES1
SCHEMBL6227879 0.90 HTT (0.43) DPP4HTTCYP1A2CES2CES1
SCHEMBL1157937 0.90 HTT (0.43) DPP4HTTCYP1A2CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1961729-B1 METHOD FOR PRODUCING TETRAFLUOROTEREPHTHALIC ACID DIFLUORIDE SUMITOMO CHEMICAL CO (JP) 2012-09-26 EP claimed
US-8017798-B2 Method for producing tetrafluoroterephthalic acid difluoride SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-09-13 US claimed
US-20090227810-A1 METHOD FOR PRODUCING TETRAFLUOROTEREPHTHALIC ACID DIFLUORIDE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-09-10 US claimed
EP-1961729-A1 METHOD FOR PRODUCING TETRAFLUOROTEREPHTHALIC ACID DIFLUORIDE Sumitomo Chemical Company, Limited (JP) 2008-08-27 EP claimed
US-11512037-B2 Process for producing dimethyl 2,3,5,6-tetrachloro-1,4-benzenedicarboxylate SDS BIOTECH K.K. (JP) 2022-11-29 US disclosed
US-20220267244-A1 PROCESS FOR PRODUCING DIMETHYL 2,3,5,6-TETRACHLORO-1,4-BENZENEDICARBOXYLATE SDS BIOTECH K.K. (JP) 2022-08-25 US disclosed
CN-101610988-B Method for producing 4-methyl-2,3,5,6-tetrafluorobenzyl alcohol SUMITOMO CO LTD 2013-04-17 CN disclosed
CN-101321720-B Method for producing tetrafluoroterephthalic acid difluoride SUMITOMO CHEMICAL CO 2012-12-26 CN disclosed
EP-1961729-B1 METHOD FOR PRODUCING TETRAFLUOROTEREPHTHALIC ACID DIFLUORIDE SUMITOMO CHEMICAL CO (JP) 2012-09-26 EP disclosed
US-8017798-B2 Method for producing tetrafluoroterephthalic acid difluoride SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-09-13 US disclosed
US-8017798-B2 Method for producing tetrafluoroterephthalic acid difluoride SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-09-13 US disclosed
US-20090227810-A1 METHOD FOR PRODUCING TETRAFLUOROTEREPHTHALIC ACID DIFLUORIDE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-09-10 US disclosed
WO-2007066529-A1 METHOD FOR PRODUCING TETRAFLUOROTEREPHTHALIC ACID DIFLUORIDE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-06-14 WO disclosed
WO-2007066532-A1 METHOD FOR PRODUCING TETRAFLUOROTEREPHTHALIC ACID DIFLUORIDE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-06-14 WO disclosed
EP-0112927-B1 RESIN FOR LENS WITH HIGH REFRACTIVE INDEX AND LENS COMPOSED OF IT MITSUI TOATSU CHEMICALS, Inc. (JP) 1987-02-11 EP disclosed
US-4522993-A COPOLYMER HAVING UNITS FROM A BIS-ALLYL HALOGENATED BENZENE DICARBOXYLATE MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1985-06-11 US disclosed
EP-0112927-A1 RESIN FOR LENS WITH HIGH REFRACTIVE INDEX AND LENS COMPOSED OF IT MITSUI TOATSU CHEMICALS, Inc. (JP) 1984-07-11 EP disclosed
US-4310680-A METAL OR METAL COMPOUND CATALYST DYNAMIT NOBEL AG (DE) 1982-01-12 US disclosed
US-4172938-A Process for producing polyamides with lactam or urea solvent and CaCl2 TEIJIN LIMITED (JP) 1979-10-30 US disclosed
US-4033754-A HERBICIDES NIPPON SODA COMPANY LIMITED (JA) 1977-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220267244-A1 PROCESS FOR PRODUCING DIMETHYL 2,3,5,6-TETRACHLORO-1,4-BENZENEDICARBOXYLATE PKD1, PKD2, BCKDK DPP4 2309/4885CA2 12/4885TTR 911/4885
US-11512037-B2 Process for producing dimethyl 2,3,5,6-tetrachloro-1,4-benzenedicarboxylate PKD1, PKD2, BCKDK DPP4 2309/4885CA2 12/4885TTR 911/4885
US-20090227810-A1 METHOD FOR PRODUCING TETRAFLUOROTEREPHTHALIC ACID DIFLUORIDE DDT, DGKA, FGFR1 DPP4 2924/4885CA2 1065/4885TTR 627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.